PDMR's Interest in Shares

RNS Number : 0889R
Synectics PLC
04 March 2021
 

 

 

RNS

 

4 March 2021

 

 

 

Synectics plc

("Synectics" or the "Group")

 

PDMR's Interest in Shares

 

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, announces that on 3 March 2021 it made an award of options ("Options"), in aggregate, over 20,000 ordinary shares of 20p each in the Company ("Ordinary Shares") to David Gavin, a Person Discharging Managerial Responsibility ("PDMRs"), under its existing Performance Share Plan ("PSP"), as detailed below:

 

Following the award, Mr Gavin's total interests in Ordinary Shares comprise:

 

 

 

 

Name

 

Number of Ordinary Shares held

Interest in Ordinary Shares in Synectics plc share schemes

Resultant total interest in Ordinary Shares

% of issued share capital

David Gavin

0

20,000

20,000

0.11%

 

Under the PSP, selected employees are entitled to exercise an option to receive a certain number of Ordinary Shares at any time after a three-year vesting period, exercisable at nil cost. The number of Ordinary Shares that are awarded at the end of the three-year period is dependent on the achievement of certain performance criteria and must be exercised within ten years of the date of award.

 

The performance criteria will be measured according to the average of the Compound Annual Growth Rate ("CAGR") of the Total Shareholder Return and the CAGR of Adjusted Underlying Diluted Earnings Per Share for periods of three years. If this average is 25% or more, 100% of that tranche of Options will vest. If this average is above 15% and below 25%, between 0% and 100% of the Options will vest (on a straight-line basis).  The baseline for calculating the CAGR of Total Shareholder Return is £1.375 per share, and the baseline for calculating the CAGR of Adjusted Underlying Diluted Earnings Per Share is 11.87 pence per share (being the actual equivalent adjusted earnings per share of the Company in the financial year to 30 November 2019).

 

The limit on the number of Ordinary Shares over which options may be awarded remains unchanged.

 

Any entitlement under the PSP will lapse on cessation of employment prior to the end of the three-year vesting period, unless cessation of employment is by reason of redundancy, ill health or death.

 

Should the performance criteria be met in full or in part, it is intended that the appropriate number of Options will be satisfied firstly from any unallocated Ordinary Shares already held within the Company's employee benefit trust with the balance to be satisfied from a new issue of Ordinary Shares.

 

Full details of the PSP were set out in the Company's Annual Report for the year ended 30 November 2019, copies of which are available on the Company's website, www.synecticsplc.com.

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Claire Stewart, Company Secretary


email: info@synecticsplc.com

www.synecticsplc.com



Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / David Coaten / Henry Willcocks

 


 

 

Ends

 

About Synectics plc

 

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

 

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

 

Find out more at www.synecticsplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUQUWUPGGMW

Companies

Synectics (SNX)
UK 100